MPTP-Induced Dopaminergic Neurons

MPTP-Induced Dopaminergic Neurons

Introduction

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">MPTP-Induced Dopaminergic Neurons</th>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:0000700](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000700)</td>
</tr>
<tr>
<td class="label">Database</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:0000700](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000700)</td>
</tr>
</table>

Mptp Induced Dopaminergic Neurons is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) is a neurotoxin that selectively destroys dopaminergic neurons in the substantia nigra, producing a precise model of Parkinson's disease in primates and mice. [@przedborski1995]

Overview

MPTP-Induced Dopaminergic Neurons

Introduction

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">MPTP-Induced Dopaminergic Neurons</th>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:0000700](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000700)</td>
</tr>
<tr>
<td class="label">Database</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:0000700](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000700)</td>
</tr>
</table>

Mptp Induced Dopaminergic Neurons is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) is a neurotoxin that selectively destroys dopaminergic neurons in the substantia nigra, producing a precise model of Parkinson's disease in primates and mice. [@przedborski1995]

Overview

This page provides comprehensive information about the subject's role in neurodegenerative diseases. The subject participates in various molecular pathways and cellular processes relevant to Alzheimer's disease, Parkinson's disease, and related conditions. [@sundstrm1990]

<!-- taxonomy-enrichment --> [@bove2012]

<!-- multi-taxonomy-enrichment -->

Multi-Taxonomy Classification

Taxonomy Database Cross-References

Morphology & Electrophysiology

• Morphology: dopaminergic neuron (source: Cell Ontology)
• Morphology can be inferred from Cell Ontology classification

PanglaoDB Marker Cross-References

• Unknown (PanglaoDB):

External Database Links

• [Cell Ontology (CL:0000700)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000700)
• [OBO Foundry (CL:0000700)](http://purl.obolibrary.org/obo/CL_0000700)
• [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
• [CellxGene Census](https://cellxgene.cziscience.com/)
• [Human Cell Atlas](https://www.humancellatlas.org/)
• [PanglaoDB](https://panglaodb.se/)

Taxonomy & Classification

PanglaoDB Marker Cross-References

• Unknown (PanglaoDB):

External Database Links

• [Cell Ontology (CL:0000700)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000700)
• [OBO Foundry (CL:0000700)](http://purl.obolibrary.org/obo/CL_0000700)
• [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
• [CellxGene Census](https://cellxgene.cziscience.com/)
• [PanglaoDB](https://panglaodb.se/)

Mechanism of Toxicity

MPTP Metabolism

• Crosses blood-brain barrier
• Converted to MPP+ by MAO-B in astrocytes
• Taken up by dopaminergic neurons via DAT
• Accumulates in mitochondria

Mitochondrial Targeting

• Inhibits complex I
• Blocks electron transport
• ATP depletion
• ROS generation

Neuropathology

Selective Vulnerability

• Substantia nigra pars compacta loss
• Ventral tegmental area spared
• Striatal terminal degeneration
• Specific neuron populations

Cellular Pathology

• Dopamine depletion
• TH-positive neuron loss
• α-Synuclein phosphorylation
• Protein aggregation

Research Models

Acute Model

• Single high-dose MPTP
• Rapid degeneration
• Used for mechanism studies

Chronic Model

• Low-dose repeated exposure
• Progressive loss
• Models prodromal PD

Subacute Model

• Multiple moderate doses
• Partial recovery possible
• Useful for intervention

Species Differences

Primates

• Most sensitive model
• Full PD-like syndrome
• Lewy bodies form
• Motor and non-motor features

Mice

• Good model system
• Motor symptoms
• Limited non-motor features
• Quick recovery potential

Other Species

• Cats, dogs, monkeys
• Variable sensitivity
• Research use varies

Biomarkers

Pre-symptomatic

• DAT imaging changes
• CSF biomarker shifts
• Metabolic alterations

During Treatment

• Dopamine depletion
• Neuronal loss markers
• Inflammation markers

Therapeutic Implications

Neuroprotection

• MAO-B inhibitors
• Complex I enhancers
• Antioxidants
• Anti-apoptotic compounds

Regeneration

• Cell transplantation
• Gene therapy
• Growth factors
• Exercise

Background

The study of Mptp Induced Dopaminergic Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

• [NCBI Gene](https://www.ncbi.nlm.nih.gov/gene/) - Gene database
• [UniProt](https://www.uniprot.org/) - Protein database